Global Allergy Diagnostics Market Report 2023: Featuring BioMerieux, Danaher, HOB Biotech, HYCOR Biomedical and Lincoln Diagnostics Among Others
Global Allergy Diagnostics Market
Dublin, March 08, 2023 (GLOBE NEWSWIRE) -- The "Allergy Diagnostics Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.
This report provides strategists, marketers and senior management with the critical information they need to assess the market.
The global allergy diagnostics market grew from $5.1 billion in 2022 to $5.66 billion in 2023 at a compound annual growth rate (CAGR) of 10.9%. The allergy diagnostics market is expected to grow to $8.52 billion in 2027 at a CAGR of 10.8%.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Major players in the allergy diagnostics market are BioMerieux SA, Danaher Corporation, HOB Biotech Group Corp. Ltd., HYCOR Biomedical, Lincoln Diagnostics Inc., Omega Diagnostics Group PLC., Siemens Healthineers AG, Thermo Fischer Scientific Inc., PerkinElmer Inc. (Euroimmun AG), R-Biopharm AG, Alcon Laboratories, Inc., Abbott Laboratories, HollisterStier Allergy, NEOGEN Corporation, AESKU.GROUP GmbH, ACON Laboratories, Erba Group, and Astra Biotech GmbH.
The allergy diagnostics market includes revenue earned by instruments such as immunoassay analyzers, ELISA analyzers, luminometers, and other instruments that are used to diagnose allergies. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
An allergy is a reaction of the immune system to an allergen that isn't normally detrimental to the human body. Allergens are foreign substances that cause allergic reactions. Certain food like peanut, milk, egg and wheat, pollen, and pet dander are a few examples of allergens. Allergy diagnostics is a procedure used by a qualified allergy specialist to evaluate if the body is allergic to a certain substance.
North America was the largest region in the allergy diagnostics market in 2022. The regions covered in the allergy diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The main types of allergy diagnostics tests are in-vivo allergy tests and in-vitro allergy tests. In-vivo allergy tests are performed on the human body to identify the cause of the allergic reaction. In-vitro allergy tests are performed in laboratories using test tubes and Petri dishes to identify the allergy-causing substance. The main products in allergy diagnostics include consumables, instruments, and luminometers. By allergens, the allergy diagnostics market is segmented into inhaled allergens, food allergens, and drug allergens. Major end-users of allergy diagnostics include diagnostic laboratories, hospital-based laboratories, and academic and research institutes.
The increased occurrences of allergic diseases will propel the growth of the allergy diagnostics market. The rise in allergy diseases has been attributed to increased environmental pollution from traffic and numerous industries. An allergic reaction is described as an abnormal immune system response to an allergen. Allergy diseases include anaphylaxis, allergic rhinitis (often referred to as "hay fever"), food allergies, skin allergies, and allergic asthma.
Avoiding the allergen is the most essential treatment for allergic disorders. As a result, proper allergy diagnosis is crucial for effective allergy treatment.
For instance, according to the American College of Allergy, Asthma, and Imuunology (ACAAI), asthma and allergic diseases were common in the US for all the age groups. Asthma affected 24 million people in the US which included more than 6 million children. Allergies were 6th leading cause of illness and costed around $18 million in excess. More than 50 million Americans suffered from allergies each year. Thus, the rise in the prevalence of allergic diseases will further support the growth of the allergic diagnostics market.
The rise in the number of collaborations and partnerships among companies operating in the allergy diagnostics industry to invent new testing methods or improve existing ones is a recent trend in the market. For instance, in August 2022, LifeMD, a US-based telehealth company announced strategic partnership between its wholly-owned subsidiary, Cleared and Allergenis, a US-based predictive data analytics company. The strategic partnership is aimed at leveraging Cleared's allergy telehealth expertise and allergenis' peanut allergy diagnostic blood test in the direct-to-customer channel.
The countries covered in the allergy diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
No. of Pages
2023 - 2027
Estimated Market Value (USD) in 2023
Forecasted Market Value (USD) by 2027
Compound Annual Growth Rate
Key Topics Covered:
1. Executive Summary
2. Allergy Diagnostics Market Characteristics
3. Allergy Diagnostics Market Trends And Strategies
4. Allergy Diagnostics Market - Macro Economic Scenario
4.1 COVID-19 Impact On Allergy Diagnostics Market
4.2 Ukraine-Russia War Impact On Allergy Diagnostics Market
4.3 Impact Of High Inflation On Allergy Diagnostics Market
5. Allergy Diagnostics Market Size And Growth
5.1. Global Allergy Diagnostics Historic Market, 2017-2022, $ Billion
5.1.1. Drivers Of The Market
5.1.2. Restraints On The Market
5.2. Global Allergy Diagnostics Forecast Market, 2022-2027F, 2032F, $ Billion
5.2.1. Drivers Of The Market
5.2.2. Restraints On the Market
6. Allergy Diagnostics Market Segmentation
6.1. Global Allergy Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
In-vivo Allergy Tests
In-vitro Allergy Tests
6.2. Global Allergy Diagnostics Market, Segmentation By Allergen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
6.3. Global Allergy Diagnostics Market, Segmentation By Products , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
6.4. Global Allergy Diagnostics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Academic and Research Institutes
7. Allergy Diagnostics Market Regional And Country Analysis
7.1. Global Allergy Diagnostics Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
7.2. Global Allergy Diagnostics Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
For more information about this report visit https://www.researchandmarkets.com/r/gdfmum
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager firstname.lastname@example.org For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900